Vertex Pharma Shares Drop After Pain Drug Setback; CEO Reshma Kewalramani Outlines Next Steps
NRI PULSE STAFF REPORTER Boston, MA, August 11, 2025: Vertex Pharmaceuticals, led by Indian American CEO Reshma Kewalramani, saw its shares tumble this month after